Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    25 August 2022

    Bio-Rad introduces anti-evolocumab antibodies for use in preclinical and clinical drug development

    HERCULES, Calif. —  Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, introduces a range of type 1 antibodies that inhibit the binding of evolocumab (Repatha®) to its target, human proprotein convertase subtilisin/kexin type 9 (P...

    26 August 2022

    Government is running out of time to support businesses in urgent need

    The British Chambers of Commerce (BCC) has written to the Prime Minister, Chancellor of the Exchequer and both leadership candidates for the Conservative Party proposing a comprehensive five-point plan to provide vital support to UK businesses. ...

    23 August 2022

    Can medical devices be discriminatory?

    The UK government has recently called for evidence of discrimination in medical devices. The aim is to identify how devices and technologies may be biased against different genders, ethnicities and other socio-demographic groups. This begs the question – can medical devices be designed ...

    23 August 2022

    Solving your drug delivery needs at PDA

    Brennan Miles, John Burke, Chris Hurlstone and Alastair Willoughby from Team Consulting will be attending the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference, live in Palm Springs from 18th-19th October. ...

    22 August 2022

    Can you do too much system engineering?

    These days, a medical device needs to be considered as one element of a connected whole. Systems engineering has become a crucial part of medical device development, but can you do too much of it? Our Head of Electronics Engineering, Peter Matthewson, discusses in a new blog post. ...

    22 August 2022

    Delivering the most viscous drug ever put in an autoinjector

    Autoinjectors offer patients a smart way to get their medication. Some drugs however can be too viscous for this type of delivery. Find out how Springboard helped a client solve the tricky problem of administering a highly viscous drug via and autoinjector, helping patients around the ...

    18 August 2022

    Computational chemistry news 2022

    Computational chemistry news from Cresset, including: custom force fields, molecular dynamics, molecular scaffolds, clustering algorithms in Spark, Cresset Discovery, small molecule design. ...

    16 August 2022

    Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

    Cambridge, UK - Evonetix, the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip des...

    16 August 2022

    Keep your facility up to standard with Guardtech’s Decontamination Team

    Cleanroom construction specialists Guardtech Group helping clients shine with their high-performance deep clean programmes ...

    15 August 2022

    Sketch club - Sketch & Social launches in Cambridge

    A bi-weekly meet-up for creatives in and around Cambridge, coming together over sketching in a fun and informal group. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 230
    • Page 231
    • Current page 232
    • Page 233
    • Page 234
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS